Bessemer Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $122M | Sell |
5,067,281
-97,810
| -2% | -$2.56M | 0.17% | 151 |
|
|
2026
Q1 | $145M | Buy |
5,165,091
+5,028,603
| +3,684% | +$134M | 0.23% | 108 |
|
|
2025
Q4 | $3.4M | Buy |
136,488
+6,727
| +5% | +$170K | 0.01% | 572 |
|
|
2025
Q3 | $3.31M | Buy |
129,761
+6,896
| +6% | +$170K | 0.01% | 412 |
|
|
2025
Q2 | $2.98M | Sell |
122,865
-9,613
| -7% | -$224K | ﹤0.01% | 413 |
|
|
2025
Q1 | $3.36M | Buy |
132,478
+13,228
| +11% | +$346K | 0.01% | 402 |
|
|
2024
Q4 | $3.16M | Sell |
119,250
-21,371
| -15% | -$580K | 0.01% | 546 |
|
|
2024
Q3 | $4.07M | Sell |
140,621
-8,299
| -6% | -$242K | 0.01% | 477 |
|
|
2024
Q2 | $4.17M | Buy |
148,920
+6,574
| +5% | +$181K | 0.01% | 393 |
|
|
2024
Q1 | $3.95M | Sell |
142,346
-30,560
| -18% | -$848K | 0.01% | 419 |
|
|
2023
Q4 | $4.98M | Sell |
172,906
-51,022
| -23% | -$1.54M | 0.01% | 370 |
|
|
2023
Q3 | $7.43M | Sell |
223,928
-14,069
| -6% | -$498K | 0.02% | 305 |
|
|
2023
Q2 | $8.73M | Buy |
237,997
+21,387
| +10% | +$832K | 0.02% | 275 |
|
|
2023
Q1 | $8.84M | Sell |
216,610
-7,702
| -3% | -$333K | 0.02% | 267 |
|
|
2022
Q4 | $11.5M | Sell |
224,312
-12,502
| -5% | -$599K | 0.03% | 239 |
|
|
2022
Q3 | $10.4M | Buy |
236,814
+13,146
| +6% | +$639K | 0.03% | 239 |
|
|
2022
Q2 | $11.7M | Sell |
223,668
-4,845
| -2% | -$247K | 0.03% | 217 |
|
|
2022
Q1 | $11.8M | Buy |
228,513
+27,844
| +14% | +$1.44M | 0.02% | 209 |
|
|
2021
Q4 | $11.8M | Buy |
200,669
+28,928
| +17% | +$1.43M | 0.02% | 203 |
|
|
2021
Q3 | $7.39M | Sell |
171,741
-337
| -0.2% | -$14.9K | 0.02% | 231 |
|
|
2021
Q2 | $6.74M | Sell |
172,078
-747
| -0.4% | -$29K | 0.01% | 239 |
|
|
2021
Q1 | $6.26M | Sell |
172,825
-32,588
| -16% | -$1.16M | 0.02% | 245 |
|
|
2020
Q4 | $7.56M | Sell |
205,413
-16,506
| -7% | -$605K | 0.02% | 225 |
|
|
2020
Q3 | $7.73M | Sell |
221,919
-86,240
| -28% | -$3.02M | 0.02% | 227 |
|
|
2020
Q2 | $9.56M | Buy |
308,159
+92,873
| +43% | +$3.16M | 0.03% | 252 |
|
|
2020
Q1 | $6.67M | Buy |
215,286
+20,352
| +10% | +$693K | 0.03% | 263 |
|
|
2019
Q4 | $7.25M | Buy |
194,934
+25,018
| +15% | +$891K | 0.02% | 277 |
|
|
2019
Q3 | $5.79M | Sell |
169,916
-8,945,037
| -98% | -$325M | 0.02% | 264 |
|
|
2019
Q2 | $375M | Sell |
9,114,953
-24,690
| -0.3% | -$980K | 1.26% | 14 |
|
|
2019
Q1 | $368M | Buy |
9,139,643
+37,670
| +0.4% | +$1.51M | 1.41% | 10 |
|
|
2018
Q4 | $377M | Buy |
9,101,973
+2,391,534
| +36% | +$99.3M | 1.64% | 6 |
|
|
2018
Q3 | $281M | Buy |
6,710,439
+6,540,368
| +3,846% | +$252M | 1.04% | 23 |
|
|
2018
Q2 | $5.86M | Buy |
170,071
+19,375
| +13% | +$662K | 0.02% | 255 |
|
|
2018
Q1 | $5.08M | Sell |
150,696
-562,322
| -79% | -$19.3M | 0.02% | 290 |
|
|
2017
Q4 | $24.5M | Sell |
713,018
-524,391
| -42% | -$17.9M | 0.1% | 142 |
|
|
2017
Q3 | $41.9M | Buy |
1,237,409
+21,980
| +2% | +$706K | 0.17% | 125 |
|
|
2017
Q2 | $38.7M | Buy |
1,215,429
+14,253
| +1% | +$449K | 0.16% | 124 |
|
|
2017
Q1 | $39M | Sell |
1,201,176
-3,969,668
| -77% | -$125M | 0.16% | 129 |
|
|
2016
Q4 | $159M | Buy |
5,170,844
+24,025
| +0.5% | +$733K | 0.73% | 35 |
|
|
2016
Q3 | $165M | Sell |
5,146,819
-113,672
| -2% | -$3.8M | 0.83% | 30 |
|
|
2016
Q2 | $176M | Sell |
5,260,491
-1,758,362
| -25% | -$56.1M | 0.96% | 21 |
|
|
2016
Q1 | $197M | Buy |
7,018,853
+139,184
| +2% | +$3.98M | 1.11% | 15 |
|
|
2015
Q4 | $211M | Buy |
6,879,669
+15,898
| +0.2% | +$500K | 1.17% | 13 |
|
|
2015
Q3 | $205M | Buy |
6,863,771
+53,341
| +0.8% | +$1.71M | 1.17% | 13 |
|
|
2015
Q2 | $217M | Sell |
6,810,430
-1,722,577
| -20% | -$56.1M | 1.13% | 12 |
|
|
2015
Q1 | $282M | Buy |
8,533,007
+6,183
| +0.1% | +$197K | 1.43% | 7 |
|
|
2014
Q4 | $252M | Buy |
8,526,824
+6,625
| +0.1% | +$190K | 1.36% | 9 |
|
|
2014
Q3 | $239M | Buy |
8,520,199
+111,459
| +1% | +$3.13M | 1.36% | 9 |
|
|
2014
Q2 | $237M | Buy |
8,408,740
+1,352,656
| +19% | +$38.6M | 1.46% | 8 |
|
|
2014
Q1 | $215M | Buy |
7,056,084
+437,296
| +7% | +$13M | 1.45% | 6 |
|
|
2013
Q4 | $192M | Buy |
6,618,788
+187,689
| +3% | +$5.46M | 1.38% | 7 |
|
|
2013
Q3 | $175M | Buy |
6,431,099
+101,919
| +2% | +$2.77M | 1.42% | 7 |
|
|
2013
Q2 | $168M | Buy |
+6,329,180
| New | +$175M | 1.51% | 3 |
|
Other funds holding PFE
Bessemer Group's PFE Position: Q2 2026 in Review
Bessemer Group reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $2.56M and leaving 5,067,281 shares worth $122M. The position accounts for 0.17% of the portfolio, ranked #151.
Bessemer Group first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $377M in Q4 2018. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bessemer Group held 5,067,281 shares of Pfizer worth $122M as of Q2 2026.
- Bessemer Group sold 97,810 Pfizer shares in Q2 2026, an estimated $2.56M.
- Pfizer made up 0.17% of Bessemer Group's portfolio in Q2 2026, its #151 holding.
- Bessemer Group first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Bessemer Group's Pfizer position peaked at $377M in Q4 2018.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.